# Phase I Study to Assess Absorption, Metabolism & Excretion of a Single Oral Dose [14C]AZD0530 in Healthy Male Volunteers

> **NCT00853983** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 6 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** [14C] AZD0530

## Key facts

- **NCT ID:** NCT00853983
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** —
- **Final completion:** 2009-04
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2009-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00853983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00853983, "Phase I Study to Assess Absorption, Metabolism & Excretion of a Single Oral Dose [14C]AZD0530 in Healthy Male Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00853983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*